BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22767636)

  • 1. Serum sclerostin increases in healthy adult men during bed rest.
    Spatz JM; Fields EE; Yu EW; Divieti Pajevic P; Bouxsein ML; Sibonga JD; Zwart SR; Smith SM
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1736-40. PubMed ID: 22767636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the combined effects of normobaric hypoxia and bed rest upon bone and mineral metabolism: Results from the PlanHab study.
    Rittweger J; Debevec T; Frings-Meuthen P; Lau P; Mittag U; Ganse B; Ferstl PG; Simpson EJ; Macdonald IA; Eiken O; Mekjavic IB
    Bone; 2016 Oct; 91():130-8. PubMed ID: 27443510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower body negative pressure treadmill exercise as a countermeasure for bed rest-induced bone loss in female identical twins.
    Zwart SR; Hargens AR; Lee SM; Macias BR; Watenpaugh DE; Tse K; Smith SM
    Bone; 2007 Feb; 40(2):529-37. PubMed ID: 17070743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute decline in serum sclerostin in response to PTH infusion in healthy men.
    Yu EW; Kumbhani R; Siwila-Sackman E; Leder BZ
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1848-51. PubMed ID: 21865370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects.
    Zerwekh JE; Ruml LA; Gottschalk F; Pak CY
    J Bone Miner Res; 1998 Oct; 13(10):1594-601. PubMed ID: 9783548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of artificial gravity during bed rest on bone metabolism in humans.
    Smith SM; Zwart SR; Heer MA; Baecker N; Evans HJ; Feiveson AH; Shackelford LC; Leblanc AD
    J Appl Physiol (1985); 2009 Jul; 107(1):47-53. PubMed ID: 19074572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerostin and DKK1 levels during 14 and 21 days of bed rest in healthy young men.
    Frings-Meuthen P; Boehme G; Liphardt AM; Baecker N; Heer M; Rittweger J
    J Musculoskelet Neuronal Interact; 2013 Mar; 13(1):45-52. PubMed ID: 23445914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
    J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sclerostin and DKK1 in relation to exercise against bone loss in experimental bed rest.
    Belavý DL; Baecker N; Armbrecht G; Beller G; Buehlmeier J; Frings-Meuthen P; Rittweger J; Roth HJ; Heer M; Felsenberg D
    J Bone Miner Metab; 2016 May; 34(3):354-65. PubMed ID: 26056021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metabolism and nutritional status during 30-day head-down-tilt bed rest.
    Morgan JL; Zwart SR; Heer M; Ploutz-Snyder R; Ericson K; Smith SM
    J Appl Physiol (1985); 2012 Nov; 113(10):1519-29. PubMed ID: 22995395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
    Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
    Ardawi MS; Al-Sibiany AM; Bakhsh TM; Rouzi AA; Qari MH
    Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant Supplementation Does Not Affect Bone Turnover Markers During 60 Days of 6° Head-Down Tilt Bed Rest: Results from an Exploratory Randomized Controlled Trial.
    Austermann K; Baecker N; Zwart SR; Fimmers R; Frippiat JP; Stehle P; Smith SM; Heer M
    J Nutr; 2021 Jun; 151(6):1527-1538. PubMed ID: 33831949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Sclerostin Increases After Acute Physical Activity.
    Pickering ME; Simon M; Sornay-Rendu E; Chikh K; Carlier MC; Raby AL; Szulc P; Confavreux CB
    Calcif Tissue Int; 2017 Aug; 101(2):170-173. PubMed ID: 28374174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia.
    Wild J; Pateisky P; Küssel L; Huf W; Ott J; Haslinger P; Knöfler M; Zeisler H
    Hypertens Pregnancy; 2014 Aug; 33(3):333-40. PubMed ID: 24568269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrogen metabolism and bone metabolism markers in healthy adults during 16 weeks of bed rest.
    Scheld K; Zittermann A; Heer M; Herzog B; Mika C; Drummer C; Stehle P
    Clin Chem; 2001 Sep; 47(9):1688-95. PubMed ID: 11514404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system.
    Arnaud SB; Sherrard DJ; Maloney N; Whalen RT; Fung P
    Aviat Space Environ Med; 1992 Jan; 63(1):14-20. PubMed ID: 1550528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.